NDTV Profit

Pfizer mulls buying Strides Arcolab's Agila Specialties - report

Pfizer is considering buying India's Agila Specialties, the injectable-medicines unit of Indian drug supplier Strides Arcolab, for a possible price of $2 billion, Bloomberg reported.
EMAIL
COMMENTS
Pfizer mulls buying Strides Arcolab's Agila Specialties - report
New York:

Pfizer is considering buying India's Agila Specialties, the injectable-medicines unit of Indian drug supplier Strides Arcolab, for a possible price of $2 billion (Rs 10,886.31 crore), Bloomberg reported on Monday.

Pfizer is doing due diligence and a deal could be reached this quarter, Bloomberg reported, citing unnamed sources.

A Pfizer spokeswoman said the company does not comment on market rumours or speculation.

Agila makes cancer treatments and antibiotics, Bloomberg said.

Copyright @ Thomson Reuters 2013



For latest news on Business, like us on Facebook and follow us on Twitter.
ALSO READ Here's How Airtel Plans To Counter Reliance Jio's Broadband Entry

Advertisement

Advertisement

GAINERS / LOSERS

Advertisement

Advertisement